Gene Page: SNCA
Summary ?
GeneID | 6622 |
Symbol | SNCA |
Synonyms | NACP|PARK1|PARK4|PD1 |
Description | synuclein alpha |
Reference | MIM:163890|HGNC:HGNC:11138|Ensembl:ENSG00000145335|HPRD:01227|Vega:OTTHUMG00000130948 |
Gene type | protein-coding |
Map location | 4q21 |
Pascal p-value | 0.012 |
Sherlock p-value | 0.516 |
Fetal beta | -1.991 |
DMG | 1 (# studies) |
Support | G2Cdb.human_clathrin G2Cdb.human_Synaptosome |
Gene in Data Sources
Gene set name | Method of gene set | Description | Info |
---|---|---|---|
CV:PGCnp | Genome-wide Association Study | GWAS | |
DMG:Nishioka_2013 | Genome-wide DNA methylation analysis | The authors investigated the methylation profiles of DNA in peripheral blood cells from 18 patients with first-episode schizophrenia (FESZ) and from 15 normal controls. | 1 |
PMID:cooccur | High-throughput literature-search | Systematic search in PubMed for genes co-occurring with SCZ keywords. A total of 3027 genes were included. | |
Literature | High-throughput literature-search | Co-occurance with Schizophrenia keywords: schizophrenia,schizophrenias | Click to show details |
GO_Annotation | Mapping neuro-related keywords to Gene Ontology annotations | Hits with neuro-related keywords: 7 | |
Network | Shortest path distance of core genes in the Human protein-protein interaction network | Contribution to shortest path in PPI network: 0.0635 |
Section I. Genetics and epigenetics annotation
Differentially methylated gene
Probe | Chromosome | Position | Nearest gene | P (dis) | Beta (dis) | FDR (dis) | Study |
---|---|---|---|---|---|---|---|
cg15452573 | 4 | 90758843 | SNCA | -0.019 | 0.77 | DMG:Nishioka_2013 |
Section II. Transcriptome annotation
General gene expression (GTEx)
Gene expression during devlopment (BrainCloud)
Footnote:
A total of 269 time points ploted, with n=38 fetal samples (x=1:38). Each triangle represents one time point.
Gene expression of temporal and spatial changes (BrainSpan)
Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes the lower 25% and upper 25% of the expression distribution.
Top co-expressed genes in brain regions
Top 10 positively co-expressed genes | ||
Gene | Pearson's Correlation | Spearman's Correlation |
PALLD | 0.91 | 0.84 |
NR2E1 | 0.87 | 0.78 |
NOTCH1 | 0.86 | 0.81 |
SOX2 | 0.86 | 0.84 |
YAP1 | 0.85 | 0.75 |
AL161668.2 | 0.85 | 0.83 |
LTBP1 | 0.85 | 0.74 |
SIX5 | 0.84 | 0.67 |
FBXL7 | 0.84 | 0.80 |
TGIF2 | 0.84 | 0.69 |
Top 10 negatively co-expressed genes | ||
Gene | Pearson's Correlation | Spearman's Correlation |
SERPINI1 | -0.31 | -0.28 |
C5orf53 | -0.31 | -0.30 |
RERGL | -0.30 | -0.35 |
CHN1 | -0.30 | -0.20 |
SERGEF | -0.30 | -0.32 |
TMEM155 | -0.29 | -0.26 |
CA4 | -0.29 | -0.26 |
NRSN1 | -0.29 | -0.25 |
NDUFB9 | -0.29 | -0.39 |
ZFAND2A | -0.29 | -0.33 |
Section III. Gene Ontology annotation
Molecular function | GO term | Evidence | Neuro keywords | PubMed ID |
---|---|---|---|---|
GO:0042802 | identical protein binding | IEA | - | |
Biological process | GO term | Evidence | Neuro keywords | PubMed ID |
GO:0007417 | central nervous system development | TAS | Brain (GO term level: 6) | 9197268 |
GO:0048169 | regulation of long-term neuronal synaptic plasticity | IEA | neuron, Synap (GO term level: 10) | - |
GO:0001963 | synaptic transmission, dopaminergic | IEA | neuron, Synap, Neurotransmitter, dopamine (GO term level: 8) | - |
GO:0048489 | synaptic vesicle transport | IEA | neuron, Synap (GO term level: 6) | - |
GO:0001956 | positive regulation of neurotransmitter secretion | IEA | Neurotransmitter (GO term level: 10) | - |
GO:0042416 | dopamine biosynthetic process | IEA | Neurotransmitter, dopamine (GO term level: 9) | - |
GO:0006644 | phospholipid metabolic process | IEA | - | |
GO:0006916 | anti-apoptosis | TAS | 10818098 | |
GO:0042493 | response to drug | IEA | - | |
GO:0040012 | regulation of locomotion | IEA | - | |
Cellular component | GO term | Evidence | Neuro keywords | PubMed ID |
GO:0019717 | synaptosome | IEA | Synap, Brain (GO term level: 7) | - |
GO:0005634 | nucleus | IEA | - | |
GO:0005737 | cytoplasm | TAS | 8248242 | |
GO:0016020 | membrane | IEA | - |
Section IV. Protein-protein interaction annotation
Interactors | Aliases B | Official full name B | Experimental | Source | PubMed ID |
---|---|---|---|---|---|
APP | AAA | ABETA | ABPP | AD1 | APPI | CTFgamma | CVAP | PN2 | amyloid beta (A4) precursor protein | - | HPRD,BioGRID | 9163350 |
BAD | BBC2 | BCL2L8 | BCL2-associated agonist of cell death | Reconstituted Complex | BioGRID | 11742726 |
BAD | BBC2 | BCL2L8 | BCL2-associated agonist of cell death | - | HPRD | 10407019 |
BAX | BCL2L4 | BCL2-associated X protein | Reconstituted Complex | BioGRID | 11742726 |
BCL2L1 | BCL-XL/S | BCL2L | BCLX | Bcl-X | DKFZp781P2092 | bcl-xL | bcl-xS | BCL2-like 1 | - | HPRD | 11742726 |
CALM1 | CALML2 | CAMI | DD132 | PHKD | calmodulin 1 (phosphorylase kinase, delta) | - | HPRD,BioGRID | 12358748 |
COL25A1 | CLAC | CLACP | collagen, type XXV, alpha 1 | - | HPRD | 15522881 |
CPOX | CPO | CPX | HCP | coproporphyrinogen oxidase | - | HPRD,BioGRID | 12059041 |
CYCS | CYC | HCS | cytochrome c, somatic | - | HPRD | 10506125 |
ELK1 | - | ELK1, member of ETS oncogene family | - | HPRD | 11279280 |
FYN | MGC45350 | SLK | SYN | FYN oncogene related to SRC, FGR, YES | - | HPRD,BioGRID | 11162638 |
GRK1 | GPRK1 | RHOK | RK | G protein-coupled receptor kinase 1 | Biochemical Activity | BioGRID | 10852916 |
GRK5 | GPRK5 | G protein-coupled receptor kinase 5 | Biochemical Activity | BioGRID | 10852916 |
GRK6 | FLJ32135 | GPRK6 | G protein-coupled receptor kinase 6 | Biochemical Activity | BioGRID | 10852916 |
LAMP2 | CD107b | LAMPB | LGP110 | lysosomal-associated membrane protein 2 | alpha-synuclein interacts with lamp2a. This interaction was modeled on a demonstrated interaction between human alpha-synuclein and rat lamp2a. | BIND | 15333840 |
MAP1B | DKFZp686E1099 | DKFZp686F1345 | FLJ38954 | FUTSCH | MAP5 | microtubule-associated protein 1B | - | HPRD,BioGRID | 10764738 |
MAPK1 | ERK | ERK2 | ERT1 | MAPK2 | P42MAPK | PRKM1 | PRKM2 | p38 | p40 | p41 | p41mapk | mitogen-activated protein kinase 1 | Affinity Capture-Western | BioGRID | 12121974 |
MAPK1 | ERK | ERK2 | ERT1 | MAPK2 | P42MAPK | PRKM1 | PRKM2 | p38 | p40 | p41 | p41mapk | mitogen-activated protein kinase 1 | - | HPRD | 11279280 |
MAPK3 | ERK1 | HS44KDAP | HUMKER1A | MGC20180 | P44ERK1 | P44MAPK | PRKM3 | mitogen-activated protein kinase 3 | Affinity Capture-Western | BioGRID | 12121974 |
MAPK8 | JNK | JNK1 | JNK1A2 | JNK21B1/2 | PRKM8 | SAPK1 | mitogen-activated protein kinase 8 | Affinity Capture-Western | BioGRID | 12121974 |
MAPK8IP1 | IB1 | JIP-1 | JIP1 | PRKM8IP | mitogen-activated protein kinase 8 interacting protein 1 | - | HPRD | 11790792 |
MAPT | DDPAC | FLJ31424 | FTDP-17 | MAPTL | MGC138549 | MSTD | MTBT1 | MTBT2 | PPND | TAU | microtubule-associated protein tau | - | HPRD,BioGRID | 10464279 |
PARK2 | AR-JP | LPRS2 | PDJ | PRKN | Parkinson disease (autosomal recessive, juvenile) 2, parkin | - | HPRD,BioGRID | 11588587 |
PLD1 | - | phospholipase D1, phosphatidylcholine-specific | - | HPRD,BioGRID | 11821392 |
PRKCE | MGC125656 | MGC125657 | PKCE | nPKC-epsilon | protein kinase C, epsilon | - | HPRD | 10407019 |
SEPT2 | DIFF6 | KIAA0158 | NEDD5 | Pnutl3 | hNedd5 | septin 2 | Affinity Capture-Western | BioGRID | 12695511 |
SEPT4 | ARTS | BRADEION | CE5B3 | H5 | MART | PNUTL2 | SEP4 | hCDCREL-2 | hucep-7 | septin 4 | Affinity Capture-Western | BioGRID | 12695511 |
SLC6A3 | DAT | DAT1 | solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 | Alpha-synuclein interacts with hDAT. | BIND | 14550771 |
SLC6A3 | DAT | DAT1 | solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 | - | HPRD,BioGRID | 12672538 |
SNCAIP | MGC39814 | SYPH1 | synuclein, alpha interacting protein | Affinity Capture-Western FRET Reconstituted Complex Two-hybrid | BioGRID | 10319874 |11331421 |11742726 |12044636 |
SNCAIP | MGC39814 | SYPH1 | synuclein, alpha interacting protein | SNCAIP interacts with SNCA. | BIND | 10319874 |
SNCAIP | MGC39814 | SYPH1 | synuclein, alpha interacting protein | - | HPRD | 10319874 |11331421 |12044636 |
SNCB | - | synuclein, beta | - | HPRD,BioGRID | 11683992 |
SQSTM1 | A170 | OSIL | PDB3 | ZIP3 | p60 | p62 | p62B | sequestosome 1 | - | HPRD | 11447312 |
TH | TYH | tyrosine hydroxylase | - | HPRD | 11943812 |
TOR1A | DQ2 | DYT1 | torsin family 1, member A (torsin A) | - | HPRD,BioGRID | 11438481 |
TUBA1A | B-ALPHA-1 | FLJ25113 | LIS3 | TUBA3 | tubulin, alpha 1a | - | HPRD | 11687285 |
UCHL1 | PARK5 | PGP9.5 | Uch-L1 | ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase) | - | HPRD | 11603807 |
YWHAB | GW128 | HS1 | KCIP-1 | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta polypeptide | - | HPRD | 10407019 |
YWHAE | 14-3-3E | FLJ45465 | KCIP-1 | MDCR | MDS | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide | - | HPRD | 10407019 |
Section V. Pathway annotation
Pathway name | Pathway size | # SZGR 2.0 genes in pathway | Info |
---|---|---|---|
KEGG ALZHEIMERS DISEASE | 169 | 110 | All SZGR 2.0 genes in this pathway |
KEGG PARKINSONS DISEASE | 133 | 78 | All SZGR 2.0 genes in this pathway |
BIOCARTA PARKIN PATHWAY | 13 | 8 | All SZGR 2.0 genes in this pathway |
PID ALPHA SYNUCLEIN PATHWAY | 33 | 25 | All SZGR 2.0 genes in this pathway |
REACTOME AMYLOIDS | 83 | 63 | All SZGR 2.0 genes in this pathway |
ONKEN UVEAL MELANOMA DN | 526 | 357 | All SZGR 2.0 genes in this pathway |
DIAZ CHRONIC MEYLOGENOUS LEUKEMIA UP | 1382 | 904 | All SZGR 2.0 genes in this pathway |
SENESE HDAC3 TARGETS DN | 536 | 332 | All SZGR 2.0 genes in this pathway |
JAATINEN HEMATOPOIETIC STEM CELL DN | 226 | 132 | All SZGR 2.0 genes in this pathway |
WAMUNYOKOLI OVARIAN CANCER GRADES 1 2 DN | 67 | 43 | All SZGR 2.0 genes in this pathway |
RODRIGUES THYROID CARCINOMA POORLY DIFFERENTIATED UP | 633 | 376 | All SZGR 2.0 genes in this pathway |
HAHTOLA SEZARY SYNDROM UP | 98 | 58 | All SZGR 2.0 genes in this pathway |
HAHTOLA MYCOSIS FUNGOIDES SKIN UP | 177 | 113 | All SZGR 2.0 genes in this pathway |
HAHTOLA MYCOSIS FUNGOIDES UP | 19 | 15 | All SZGR 2.0 genes in this pathway |
TANG SENESCENCE TP53 TARGETS UP | 33 | 20 | All SZGR 2.0 genes in this pathway |
XU HGF TARGETS INDUCED BY AKT1 48HR DN | 27 | 17 | All SZGR 2.0 genes in this pathway |
DAIRKEE TERT TARGETS UP | 380 | 213 | All SZGR 2.0 genes in this pathway |
CEBALLOS TARGETS OF TP53 AND MYC DN | 38 | 31 | All SZGR 2.0 genes in this pathway |
SHETH LIVER CANCER VS TXNIP LOSS PAM1 | 229 | 137 | All SZGR 2.0 genes in this pathway |
AMIT SERUM RESPONSE 20 MCF10A | 21 | 10 | All SZGR 2.0 genes in this pathway |
ONDER CDH1 TARGETS 2 DN | 464 | 276 | All SZGR 2.0 genes in this pathway |
LE EGR2 TARGETS DN | 108 | 84 | All SZGR 2.0 genes in this pathway |
TARTE PLASMA CELL VS PLASMABLAST UP | 398 | 262 | All SZGR 2.0 genes in this pathway |
MOREAUX MULTIPLE MYELOMA BY TACI UP | 412 | 249 | All SZGR 2.0 genes in this pathway |
VERHAAK AML WITH NPM1 MUTATED DN | 246 | 180 | All SZGR 2.0 genes in this pathway |
HOEGERKORP CD44 TARGETS TEMPORAL DN | 25 | 16 | All SZGR 2.0 genes in this pathway |
IVANOVA HEMATOPOIESIS MATURE CELL | 293 | 160 | All SZGR 2.0 genes in this pathway |
BLALOCK ALZHEIMERS DISEASE DN | 1237 | 837 | All SZGR 2.0 genes in this pathway |
LEE AGING CEREBELLUM DN | 86 | 66 | All SZGR 2.0 genes in this pathway |
BROWNE HCMV INFECTION 48HR UP | 180 | 125 | All SZGR 2.0 genes in this pathway |
XU GH1 EXOGENOUS TARGETS UP | 85 | 50 | All SZGR 2.0 genes in this pathway |
RODWELL AGING KIDNEY UP | 487 | 303 | All SZGR 2.0 genes in this pathway |
XU GH1 AUTOCRINE TARGETS UP | 268 | 157 | All SZGR 2.0 genes in this pathway |
HOWLIN CITED1 TARGETS 1 UP | 35 | 25 | All SZGR 2.0 genes in this pathway |
ZHENG BOUND BY FOXP3 | 491 | 310 | All SZGR 2.0 genes in this pathway |
MARTINEZ RB1 TARGETS UP | 673 | 430 | All SZGR 2.0 genes in this pathway |
MARTINEZ TP53 TARGETS DN | 593 | 372 | All SZGR 2.0 genes in this pathway |
MARTINEZ RB1 AND TP53 TARGETS DN | 591 | 366 | All SZGR 2.0 genes in this pathway |
GRADE COLON AND RECTAL CANCER DN | 101 | 65 | All SZGR 2.0 genes in this pathway |
MALONEY RESPONSE TO 17AAG DN | 79 | 45 | All SZGR 2.0 genes in this pathway |
MOOTHA MITOCHONDRIA | 447 | 277 | All SZGR 2.0 genes in this pathway |
YOSHIMURA MAPK8 TARGETS UP | 1305 | 895 | All SZGR 2.0 genes in this pathway |
SWEET LUNG CANCER KRAS DN | 435 | 289 | All SZGR 2.0 genes in this pathway |
VALK AML CLUSTER 8 | 26 | 17 | All SZGR 2.0 genes in this pathway |
MIKKELSEN IPS ICP WITH H3K4ME3 AND H327ME3 | 126 | 83 | All SZGR 2.0 genes in this pathway |
HAHTOLA CTCL CUTANEOUS | 26 | 19 | All SZGR 2.0 genes in this pathway |
DANG REGULATED BY MYC DN | 253 | 192 | All SZGR 2.0 genes in this pathway |
RAGHAVACHARI PLATELET SPECIFIC GENES | 70 | 46 | All SZGR 2.0 genes in this pathway |
PILON KLF1 TARGETS UP | 504 | 321 | All SZGR 2.0 genes in this pathway |
BRUINS UVC RESPONSE VIA TP53 GROUP A | 898 | 516 | All SZGR 2.0 genes in this pathway |
ISSAEVA MLL2 TARGETS | 62 | 35 | All SZGR 2.0 genes in this pathway |
VANDESLUIS COMMD1 TARGETS GROUP 3 UP | 89 | 50 | All SZGR 2.0 genes in this pathway |
SERVITJA ISLET HNF1A TARGETS UP | 163 | 111 | All SZGR 2.0 genes in this pathway |
PLASARI NFIC TARGETS BASAL UP | 27 | 17 | All SZGR 2.0 genes in this pathway |
PHONG TNF RESPONSE VIA P38 PARTIAL | 160 | 106 | All SZGR 2.0 genes in this pathway |
FOSTER KDM1A TARGETS UP | 266 | 142 | All SZGR 2.0 genes in this pathway |
LIM MAMMARY STEM CELL UP | 489 | 314 | All SZGR 2.0 genes in this pathway |
Section VI. microRNA annotation
miRNA family | Target position | miRNA ID | miRNA seq | ||
---|---|---|---|---|---|
UTR start | UTR end | Match method | |||
miR-153 | 459 | 465 | m8 | hsa-miR-153 | UUGCAUAGUCACAAAAGUGA |
miR-324-3p | 131 | 137 | 1A | hsa-miR-324-3p | CCACUGCCCCAGGUGCUGCUGG |
miR-495 | 417 | 423 | 1A | hsa-miR-495brain | AAACAAACAUGGUGCACUUCUUU |
miR-539 | 89 | 96 | 1A,m8 | hsa-miR-539 | GGAGAAAUUAUCCUUGGUGUGU |
miR-7 | 120 | 127 | 1A,m8 | hsa-miR-7SZ | UGGAAGACUAGUGAUUUUGUUG |
- SZ: miRNAs which differentially expressed in brain cortex of schizophrenia patients comparing with control samples using microarray. Click here to see the list of SZ related miRNAs.
- Brain: miRNAs which are expressed in brain based on miRNA microarray expression studies. Click here to see the list of brain related miRNAs.